Latest News about NTRA
Recent news which mentions NTRA
Stocks That Hit 52-Week Highs On Friday
January 15, 2021
From Benzinga
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
January 15, 2021
From Benzinga
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
From Benzinga
These Were the 5 Best Diagnostics Stocks of 2020
January 09, 2021
From Motley Fool
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
December 29, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 28, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 22, 2020
From Benzinga
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
December 22, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 18, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 14, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 11, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
December 11, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 10, 2020
From Benzinga
The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations
December 10, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 09, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod
December 02, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 01, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
November 06, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
November 06, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
November 05, 2020
From Benzinga
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
From Benzinga
The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data
October 13, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
October 12, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For October 8, 2020
October 08, 2020
From Benzinga
The Daily Biotech Pulse: Gilead, Lilly COVID-19 Treatment Supply Agreements, CareDx's Positive Preannouncement, Aziyo Biologics Debuts On Wall Street
October 08, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.